Reach Us +1-470-347-1923
Self-efficacy, Physical Activity and QOL in People with MS | OMICS International
ISSN: 2155-9562
Journal of Neurology & Neurophysiology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Self-efficacy, Physical Activity and QOL in People with MS

Cecilie Fjeldstad* and Gabriel Pardo

OMRF Multiple Sclerosis Center of Excellence, 820 NE 15th Street, Oklahoma City, USA

Corresponding Author:
Cecilie Fjeldstad
OMRF Multiple Sclerosis Center of Excellence
820 NE 15th Street, Oklahoma City, USA
Tel: 405.271.8001, extn 58089
Fax: 405.271.2319
E-mail: [email protected]

Received date: January 21, 2014; Accepted date: February 24, 2014; Published date: March 01, 2014

Citation: Fjeldstad C, Pardo G (2014) Self-efficacy, Physical Activity and QOL in People with MS. J Neurol Neurophysiol 5:194. doi:10.4172/2155-9562.1000194

Copyright: © 2014 Fjeldstad C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Neurology & Neurophysiology


Self-Efficacy is part of the social-cognitive theory defined as the belief that one can successfully cope with challenging situations and attain certain goals. It has been suggested this principle can be applied to physical and psychological quality of life in individuals with Multiple Sclerosis (MS). Objective: To examine if self-efficacy and physical activity have relationships with quality of life (QOL) in individuals with MS. Methods: 109 individuals with MS participated in this study. Each individual completed the Multiple Sclerosis Self-Efficacy scale (MSSE), the Multiple Sclerosis Impact Scale (MSIS-29), and the Good in Leisure-Time Exercise Questionnaire (GLTEQ). Pearson product moment correlation coefficients were computed for self-efficacy, physical activity and QOL. Results: The sample (n=109) was composed as follows, females (75%), relapsing remitting form of MS (81%), married (68%), employed (44%). Time since MS diagnosis was 7.6 years (SE=0.62). There were moderately high negative correlations between MSSE and QOL physical component (r=-0.65, p<0.01) and psychological component (r=-0.63, p<0.01), indicating that individuals with increased sense of self-efficacy experienced less psychological issues and an increased level of participation in physical tasks. There was a low negative but significant correlation between total time spent in leisure activity and QOL physical component (r=-0.21, p<0.05), but not for QOL psychological component. Physical activity has a negative correlation with physical impact of QOL (r=-0.21, p<0.05) and no correlation with psychological component (p>0.05). Conclusion: The results of this study demonstrate that with increased self-efficacy there is an increase in QOL on both physical and psychological components, which is important for increased independence and functionality in individuals with MS.


Multiple sclerosis; Self-efficacy; Quality of life; Physical activity


Multiple Sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS) with both inflammatory and degenerative components. It can present with an array of symptoms such as visual disturbances, motor and sensory deficits, bladder and sexual dysfunction, and psychological issues to include depression, anxiety, and cognitive dysfunction [1].

The diagnosis of MS, given the chronic nature of the disease and the fact that it implies an un-predictable path to variable degrees of disability, can have a great psychological impact and a distressing effect on quality of life (QOL). Given the variety and severity of symptoms in MS, often not visible to other people, coping mechanisms may be compromised and disrupt many aspects of life from personal (family and relationships) to professional (employment). This may impact an individuals’ self-efficacy.

Self-efficacy in MS

Self-Efficacy is part of the social-cognitive theory that involves beliefs that one can successfully cope with challenging situations and have the ability to overcome them [2]. An individual’s level of selfefficacy is often influenced by their accomplishments or capacity of performance, verbal persuasion, and the interpretation of psychological and affective states [2]. Individuals with strong self-efficacy beliefs will more likely set higher personal goals believing they will successfully achieve them. In contrast, someone with low self-efficacy beliefs will be more likely to set lower personal goals, as they do not believe they will be able to achieve high objectives. In the context of a chronic illness, their beliefs may affect their own perception of the condition, the impact the illness will have on their life, and to which capacity they are able to handle the disease. Previous studies have shown high self-efficacy to be a predictor of health related behavior such as adherence to medication [3,4], decreased depression [5,6] and increased participation in physical activity [7-11]. Self-efficacy has been demonstrated to be a predictor of psychological improvement in individuals with chronic diseases such as cancer [12], rheumatoid arthritis [13,14], fibromyalgia [15] and MS [16,17].

Physical activity in MS

Participation in physical activity (PA) of individuals diagnosed with MS is generally low [18], especially in those that complain of multiple or worsening of symptoms [9,19] and those that report high levels of fatigue or difficulty walking [20]. In the past, individuals diagnosed with MS were recommended not to engage in any physical activity in order to avoid even a slight increase in core body temperature which may worsen neurological function, known as Uhthoff’s phenomenon [21]. More recently it has been demonstrated that individuals with MS benefit from physical activity in a similar way to the non-diseased population [22] and experience improvement in their fatigue levels [23]. Participation in physical activity can be greatly compromised in the MS population as the disease presents with both physical (spasticity, muscle weakness, ataxia, fatigue, and pain), and psychological (emotional state, anxiety and depression) symptoms that decrease the ability and willingness to do so.

Quality of life in MS

Quality of life (QOL) is affected in a large number of individuals living with chronic diseases like MS [24,25]. The unpredictable clinical course and absence of a curative treatment in MS greatly affect the psychological QOL, with about 50% of individuals experiencing depression at some point during the course of the disease [26]. Individuals with self-reported more rapidly progressive types of MS usually experience greater disability and impairment, and thus often have lower QOL [27]. However, one study showed that duration of disease positively correlated with better QOL, despite greater physical disability as measured by expanded disability status scale (EDSS) [28-30], possibly due to the capacity to adjust to the effects of the disease and accept limitations over time. Participation in physical activity has shown to improve QOL in MS individuals [29,30] with the most active individuals reporting higher levels of health related QOL (HRQOL) on both physical and mental components [31].


The purpose of this study is to identify the relationship between physical activity level and self-efficacy with components of QOL. Our hypothesis is that individuals with low self-efficacy would also report decreased quality of life and have less participation in physical activities. Understanding this process can lead to interventions that will offer better results in the comprehensive management of MS by identifying barriers to patient’s participation in their own care.

Materials and Methods


Patients were recruited from a single specialized MS center at the time of scheduled office visits and data was collected as part of routine clinical assessments. The sample was a convenience sample and consisted of a total of 109 subjects with diagnosis of MS following 2010 McDonald criteria [32], with mean age 45 years, height 168 cm, weight 80 kg and mean duration since diagnosis of 7.6 years. The sample was75% females, 68% married, 44% employed, 40% with partial college education, and 38% being college graduates. Of the 109 individuals, 81% had relapsing remitting MS (RR-MS); 14% had secondary progressive MS (SP-MS); 5% had primary progressive (PP-MS).All of them were ambulatory without aids but ankle-foot orthosis and peroneal nerve electric stimulators to compensate for foot drop were allowed.

The study protocol was approved by the institutional review board, and all participants in the study provided written informed consent prior to data collection. All subjects had the cognitive ability to read and sign informed consent as determined by clinical assessment of the treating neurologist.

Protocol for acquisition

Each individual completed the following questionnaires: Multiple Sclerosis Self-Efficacy scale (MSSE) [33], a disease-specific 14-item questionnaire with a 6-point scale, ranging from 1 (strongly disagree) to 6 (strongly agree). The MSSE has been proven to be reliable and is a useful tool in assessment of psychological adjustments in both clinical and research settings [33]. Total scores range from 14 to 84, where a higher score indicates an elevated level of self-efficacy.

The Multiple Sclerosis Impact Scale (MSIS-29), a disease-specific, self-administered questionnaire asking about the day to day impact that MS has had on life for the immediate previous two weeks. It includes physical (20 items) and psychological (9 items) subscales [34], and is proven to be a useful tool in the assessment of disease impact and quality of life in community [34], hospital setting [35] and in clinical research [36]. It is a 29-item questionnaire and is scored as follows: 1=not at all, 2=a little, 3=moderately, 4=quite a bit, 5=extremely, for evaluating the degree of an experienced problem the last two weeks. The score ranges from minimum of 29 to a maximum of 145, with higher scores indicating greater impact of the disease on the individual’s QOL.

The Good in Leisure-Time Exercise Questionnaire (GLTEQ) [37], is a simple generic measure of physical activity that is widely used in clinical and epidemiological settings. It is a self-administered twoitem questionnaire that measures an individual’s physical activity level, with the first question determining the average number of times an individual participated in strenuous (e.g., jogging), moderate (e.g., fast pace walking) and mild exercise (e.g., easy pace walking), for more than 15 minutes during their free time in a typical 7-day period. These frequencies are then multiplied by nine, five, and three metabolic equivalents respectively and then summed to a total single measure of physical activity. In this particular study, we only included the first question in the analysis, as it provides more information of the amount of PA, as done in previous research [38]. The second question is ordinal in nature and has three options (1=often, 2=sometimes, 3=never/rarely) and measures how often the individual engages in any regular activity long enough to work up a sweat or rapid beating of the heart. Evidence has shown that GLTEQ gives a valid measure of physical activity in individuals diagnosed with MS [39].

Data analysis

Descriptive analyses are presented as mean ± standard errors and were carried out for all variables in the group. The relationship among scores from the three measures was examined using Pearson product moment correlation coefficients. All statistical analysis was performed using SPSS, version 16.0 (SPSS Inc, Chicago, IL, USA). Statistical significance was set at p ≤ 0.05. Demographic characteristics of the sample are displayed in Table 1.

Age (yrs) 45.05± 1.13
Height (cm) 168.00 ± 0.01
Weight (kg) 79.70 ± 2.33
MS yrs   7.62 ± 0.62

Table 1: Subject Characteristics (n=109).


Self-efficacy (MSSE) and quality of life (MSIS-29) psychological and physical impact

A moderate negative correlation between MS self-efficacy (MSSE) and quality of life (MSIS-29) psychological impact of MS (r=-0.63, p<0.01) was demonstrated, indicating that as levels of self-efficacy increase, the psychological impact on QOL decreases (Figure 1). There was a moderate negative correlation between self-efficacy and physical impact of MS (r=-0.65, p<0.01), with greater self-efficacy being associated with a lesser impact of physical deficits on QOL (Figure 2).


Figure 1: Self-efficacy (MSSE) and QOL (MSIS-29) psychological impact of MS.


Figure 2: Self-efficacy (MSSE) and QOL (MSIS-29) physical impact of MS.

Physical activity and MSIS-29 psychological and physical impact

A weak negative correlation was found between total time spent in leisure time physical activity and quality of life physical impact (r=-0.21, p<0.05), suggesting the less physical impact MS had on individuals, the more time they spent in physical activity, (Figure 3).No correlation of significance was found for time spent in physical activity and psychological impact of MS (p>0.05) (Figure 4).


Figure 3: Time spent in physical activity (PA) and QOL (MSIS-29) physical impact of MS.


Figure 4: Time spent in physical activity (PA) and QOL (MSIS-29) psychological impact of MS.

Discussion and Conclusion

This study provided information of MS self-efficacy and the time spent in physical activity and its effect on quality of life, both physical and mental, in MS individuals. A moderate relationship was evident, with those individuals having increased levels of self-efficacy reporting a lesser mental and physical impact of their underlying disease on QOL.A weaker relationship was found between time spent participating in physical activity and the physical impact component of quality of life.

Participation in physical activity may help minimize some of the symptoms associated with MS, to include fatigue, ambulation and postural balance, due to increased muscle strength [40]. It may also help decrease the risk of developing secondary diseases that result from sedentary lifestyles and inactivity such as cardiovascular disease and osteoporosis. Many factors influence the ability and willingness to engage in regular physical activity in MS. An individualized program that adapts to the participant’s limitations is recommended. Some modalities include aquatics and resistance training for MS individuals affected by thermo-sensitivity, as the core temperature will not increase as much with this type of exercise as it does with others such as running.

Quality of life is commonly compromised in MS individuals. Studies have established that QOL can be influenced by factors such as self-efficacy and physical activity, with an increase in quality of life often seen in individuals that report greater self-efficacy and more participation in physical activity [41]. A recent study showed that selfefficacy is a significant predictor of self-reported physical, cognitive and social function [42]. Those results coincide with some of the results of this study, where we demonstrated that individuals with greater selfefficacy reported less psychological and physical impact from MS in their QOL. In addition, this investigation found that individuals that spent more time participating in physical activity reported less physical impact of MS and thus increased physical independence. This positive effect was not found for time spent in physical activity and psychological impact.

There are many ways to obtain measures of physical activity levels in individuals with MS. In this study, amount of time spent exercising was measured by self-report questionnaires and not by objective measures often used by other researchers [43,44]. One previous study was able to detect differences in physical activity levels between MS individuals compared to a sedentary control group by the use of accelerometers but did not find any significant difference by self-report in the same study [44]. The use of both objective means and self-report as measures of physical activity has been previously validated [39].

The predominance of females (75%) in this study reflects the demographics of MS. Two of the 3 instruments used in this study are disease-specific, making the results not generalizable to other chronic entities.

In conclusion, this study showed that with greater self-efficacy there is a decrease in the amount of impact MS has on the individual’s physical and psychological components of QOL. This is important for overall increased independence and functionality in the MS population. Determining self-efficacy reveals important information regarding how individuals handle, cope and adjust to having a chronic disease like MS, influencing participation in self-care and disease management. It is important to educate MS patients about the benefit of physical activity to promote better, healthier and functional independent lifestyles. Selfefficacy should be incorporated in the comprehensive assessment and management of MS to improve long-term outcomes.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 12189
  • [From(publication date):
    March-2014 - Nov 20, 2018]
  • Breakdown by view type
  • HTML page views : 8378
  • PDF downloads : 3811

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version